eF-site ID 5grg-ABCD PDB Code 5grg Chain A, B, C, D click to enlarge Title Crystal structure of dual peptide from EBV in complex with HLA-A*11:01 Classification IMMUNE SYSTEM Compound HLA class I histocompatibility antigen, A-11 alpha chain Source Homo sapiens (Human) (5GRG) Sequence A:  GSHSMRYFYTSVSRPGRGEPRFIAVGYVDDTQFVRFDSDA ASQRMEPRAPWIEQEGPEYWDQETRNVKAQSQTDRVDLGT LRGYYNQSEDGSHTIQIMYGCDVGPDGRFLRGYRQDAYDG KDYIALNEDLRSWTAADMAAQITKRKWEAAHAAEQQRAYL EGRCVEWLRRYLENGKETLQRTDPPKTHMTHHPISDHEAT LRCWALGFYPAEITLTWQRDGEDQTQDTELVETRPAGDGT FQKWAAVVVPSGEEQRYTCHVQHEGLPKPLTLRW B:  IQRTPKIQVYSRHPAENGKSNFLNCYVSGFHPSDIEVDLL KNGERIEKVEHSDLSFSKDWSFYLLYYTEFTPTEKDEYAC RVNHVTLSQPKIVKWDRDM C:  SSCSSC D:  PLSK Description Functional site 1) chain A residue 29 type sequence D description binding site for residue GOL A 301 source : AC1 2) chain A residue 30 type sequence D description binding site for residue GOL A 301 source : AC1 3) chain B residue 63 type sequence Y description binding site for residue GOL A 301 source : AC1 4) chain A residue 188 type sequence H description binding site for residue GOL A 302 source : AC2 5) chain A residue 189 type sequence M description binding site for residue GOL A 302 source : AC2 6) chain B residue 81 type sequence R description binding site for residue GOL A 302 source : AC2 7) chain B residue 90 type sequence P description binding site for residue GOL A 302 source : AC2 8) chain B residue 92 type sequence I description binding site for residue GOL A 302 source : AC2 9) chain A residue 191 type sequence H description binding site for residue GOL B 101 source : AC3 10) chain A residue 192 type sequence H description binding site for residue GOL B 101 source : AC3 11) chain B residue 34 type sequence D description binding site for residue GOL B 101 source : AC3 12) chain B residue 83 type sequence N description binding site for residue GOL B 101 source : AC3 13) chain B residue 84 type sequence H description binding site for residue GOL B 101 source : AC3 14) chain B residue 85 type sequence V description binding site for residue GOL B 101 source : AC3 15) chain A residue 21 type sequence R description binding site for residue GOL B 102 source : AC4 16) chain B residue 33 type sequence S description binding site for residue GOL B 102 source : AC4 17) chain B residue 35 type sequence I description binding site for residue GOL B 102 source : AC4 18) chain B residue 51 type sequence H description binding site for residue GOL B 102 source : AC4 19) chain B residue 66 type sequence Y description binding site for residue GOL B 102 source : AC4 20) chain A residue 86 type CARBOHYD sequence N description N-linked (GlcNAc...) asparagine => ECO:0000269|PubMed:19159218 source Swiss-Prot : SWS_FT_FI4 21) chain B residue 2 type MOD_RES sequence Q description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 22) chain A residue 73 type MOD_RES sequence T description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 23) chain A residue 84 type MOD_RES sequence Y description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 24) chain A residue 143 type MOD_RES sequence T description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 25) chain A residue 146 type MOD_RES sequence K description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 26) chain A residue 171 type MOD_RES sequence Y description Pyrrolidone carboxylic acid; in form pI 5.3 => ECO:0000269|PubMed:7554280 source Swiss-Prot : SWS_FT_FI1 27) chain B residue 1 type CARBOHYD sequence I description N-linked (Glc) (glycation) isoleucine; in hemodialysis-associated amyloidosis => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI2 28) chain A residue 159 type CARBOHYD sequence Y description N-linked (Glc) (glycation) isoleucine; in hemodialysis-associated amyloidosis => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI2 29) chain B residue 19 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 30) chain B residue 41 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 31) chain B residue 48 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 32) chain B residue 58 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 33) chain B residue 91 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 34) chain B residue 94 type CARBOHYD sequence K description N-linked (Glc) (glycation) lysine; in vitro => ECO:0000269|PubMed:7918443 source Swiss-Prot : SWS_FT_FI3 35) chain B residue 78-84 type prosite sequence YACRVNH description IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YACRVNH source prosite : PS00290 36) chain A residue 257-263 type prosite sequence YTCHVQH description IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YACRVNH source prosite : PS00290

Display surface Download Links